The beneficial effects of beta-blocker and calcium-channel blocker on atrial fibrillation in patients with chronic heart failure

被引：0
作者：
Tamaki, S [1 ]
Yamada, T [1 ]
Mine, T [1 ]
Morita, T [1 ]
Kioka, H [1 ]
Tsukamoto, Y [1 ]
Masuda, M [1 ]
Okuda, K [1 ]
Fukunami, M [1 ]
机构：
[1] Osaka Gen Med Ctr, Div Cardiol, Osaka, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2005年 / 11卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2005.08.235
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [21] Is Achieved Heart Rate a Surrogate Maker during Titration of Beta-blocker in Heart Failure with Atrial Fibrillation?
    Kato, Naoko
    Kinugawa, Koichiro
    Imamura, Teruhiko
    Muraoka, Hironori
    Minatsuki, Shun
    Inaba, Toshiro
    Maki, Hisataka
    Hatano, Masaru
    Yao, Atsushi
    Komuro, Issei
    Nagai, Ryozo
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S29 - S29
  • [22] Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis
    Nasr, Imad Abi
    Bouzamondo, Anissa
    Hulot, Jean-Sebastien
    Dubourg, Olivier
    Le Heuzey, Jean-Yves
    Lechat, Philippe
    EUROPEAN HEART JOURNAL, 2007, 28 (04) : 457 - 462
  • [23] Achieved Dose of Beta-Blocker but not Achieved Heart Rate Predicts Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation
    Kato, Naoko
    Kinugawa, Koichiro
    Imamura, Teruhiko
    Muraoka, Hironori
    Minatsuki, Shun
    Inaba, Toshiro
    Maki, Hisataka
    Hatano, Masaru
    Yao, Atsushi
    Komuro, Issei
    Nagai, Ryozo
    CIRCULATION, 2013, 128 (22)
  • [24] CALCIUM-CHANNEL BLOCKER NISOLDIPINE IN CHRONIC-RENAL-FAILURE
    BLAU, A
    HERZOG, D
    SHECHTER, P
    SACHS, D
    ELIAHOU, HE
    RENAL FAILURE, 1990, 12 (02) : 113 - 119
  • [25] Effects of beta-blocker therapy on clinical outcomes in Japanese patients with chronic heart failure.
    Kawana, M
    Matsuda, N
    Kasanuki, H
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (11) : A41 - A41
  • [26] A COMPARISON OF THE EFFICACY AND SAFETY OF A BETA-BLOCKER, A CALCIUM-CHANNEL BLOCKER, AND A CONVERTING-ENZYME-INHIBITOR IN HYPERTENSIVE BLACKS
    SAUNDERS, E
    WEIR, MR
    KONG, BW
    HOLLIFIELD, J
    GRAY, J
    VERTES, V
    SOWERS, JR
    ZEMEL, MB
    CURRY, C
    SCHOENBERGER, J
    WRIGHT, JT
    KIRKENDALL, W
    CONRADI, EC
    JENKINS, P
    MCLEAN, B
    MASSIE, B
    BERENSON, G
    FLAMENBAUM, W
    ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (08) : 1707 - 1713
  • [27] Benefit of exercise training in patients with chronic heart failure treated with beta-blocker
    Gaita, D
    Branea, I
    Dragulescu, SI
    Mancas, S
    Gaita, A
    Dragan, S
    Pescariu, S
    Mut, B
    Dina, C
    Sarau, CA
    EUROPEAN HEART JOURNAL, 2001, 22 : 685 - 685
  • [28] THE BENEFICIAL EFFECT OF A CALCIUM-CHANNEL BLOCKER, DILTIAZEM, ON THE ISCHEMIC-REPERFUSED HEART
    WEISHAAR, RE
    BING, RJ
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1980, 12 (10) : 993 - 1009
  • [29] A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.
    Eichhorn, E
    Domanski, M
    Krause-Steinrauf, H
    Anderson, J
    Boardman, K
    Bristow, M
    Carson, P
    Colling, C
    Greenberg, B
    Lavori, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22) : 1659 - 1667
  • [30] Effect of beta-blocker treatment on mortality in unselected patients with atrial fibrillation
    Fauchier, L.
    Gorin, L.
    Nonin, E.
    Rauzy, B.
    Grimard, C.
    Pierre, B.
    Breard, G.
    De labriolle, A.
    Babuty, D.
    Charbonnier, B.
    EUROPEAN HEART JOURNAL, 2008, 29 : 536 - 536
12345